Hepatitis C in alcohol dependence: Drinking versus disulfiram

Journal of Addictive Diseases

Volumn 24, Issue 2, 2005, Pages 77-89

  Kulig, Clark C ^a   Beresford, Thomas P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Alcohol dependence; Disulfiram; Hepatitis C

Indexed keywords

ANTIVIRUS AGENT; DISULFIRAM;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRINKING BEHAVIOR; DRUG FEVER; FATIGUE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER INJURY; LIVER TOXICITY; MALAISE; NAUSEA; PATIENT MONITORING; PROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

ALCOHOL DETERRENTS; ALCOHOLISM; DISULFIRAM; HEPATITIS C; HUMANS; LIVER;

EID: 18044373626     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v24n02_07     Document Type: Article

References (44)

1. Nalpas B, Thiers V, Pol S, Driss F, Thepot V, Berthelot P, Brechot C. Hepatitis C viremia and anti-HCV antibodies in alcoholics. Journal of Hepatology. 1992; 14:381-4.
2. Anonymous. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. Journal of Hepatology. 1999; 31:3-8.
3. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. [see comment]. Archives of General Psychiatry. 1992; 49:876-80.
4. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. American Journal of Psychiatry. 1995; 152:613-5.
5. Anonymous. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical & Experimental Research. 1998; 22:1300-11.
6. Azrin NH, Sisson RW, Meyers R, Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. Journal of Behavior Therapy & Experimental Psychiatry. 1982; 13:105-12.
7. Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D. Disulfiram treatment of alcoholism. British Journal of Psychiatry. 1992; 161:84-9.
8. Vaillant GE. The Natural History of Alcoholism Revisited. Cambridge, MA: Harvard University Press, 1995.
9. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA. 1986; 256:1449-55.
10. Knutsen, B. Complication with Antabuse. Tidssk Nor Laegeforen 1949; 69: 436-40.
11. Martin B, Clapp L, Bridgeford D, Amponsah A, Bialkowski D, Lyons LM, Beresford, TP. Compliance to supervised disulfiram therapy: A comparison of voluntary and court-ordered patients. American Journal on Addiction 2003; 12:137-43.
12. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine. 1999; 341:556-62.
13. Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, Hultcrantz R. Chronic hepatitis C in alcoholic patients: Prevalence, genotypes, and correlation to liver disease. Scandinavian Journal of Gastroenterology. 1995; 30: 1113-8.
14. Caldwell SH, Jeffers LJ, Ditomaso A, Millar A, Clark RM, Rabassa A, Reddy KR, De Medina M, Schiff ER. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. American Journal of Gastroenterology. 1991; 86:1219-23.
15. Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T, Yamamoto S. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology. 1991; 14:985-9.
16. Henry JA, Moloney C, Rivas C, Goldin RD. Increase in alcohol related deaths: Is hepatitis C a factor? Journal of Clinical Pathology. 2002; 55:704-7.
17. Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, Seeff LB, National Heart L, Blood Institute Study G. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of Internal Medicine. 2001; 134:120-4.
18. Dufour MC. What is moderate drinking? Defining "drinks" and drinking levels. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse & Alcoholism. 1999; 23:5-14.
19. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, Valla DC. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver International 2003; 23:45-53.
20. Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Croce LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study. Gut. 1999; 44:874-80.
21. Okazaki T, Yoshihara H, Suzuki K, Yamada Y, Tsujimura T, Kawano K, Abe H. Efficacy of Interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scandinavian Journal of Gastroenterology. 1994; 29:1039-43.
22. Ohnishi K, Matsuo S, Matsutani K, Itahashi M, Kakihara K, Suzuki K, Ito S, Fujiwara K. Interferon therapy for chronic hepatitis C in habitual drinkers: Comparison with chronic hepatitis C in infrequent drinkers. American Journal of Gastroenterology. 1996; 91:1374-9.
23. Sarbah SA, Younossi ZM. Hepatitis C: An update on the silent epidemic. Journal of Clinical Gastroenterology. 2000; 30:125-43.
24. Maddrey WC. Alcohol-induced liver disease. Clinics in Liver Disease. 2000; 4:115-31, vii.
25. Degos F. Natural history of hepatitis C virus infection. Nephrology Dialysis Transplantation. 1996; 11:16-8.
26. Brewer C. Supervised disulfiram in alcoholism. British Journal of Hospital Medicine. 1986; 35:116, 118-9.
27. Brewer C. Patterns of compliance and evasion in treatment programmes which include supervised disulfiram. Alcohol & Alcoholism. 1986; 21:385-8.
28. Brewer C. Supervised Antabuse therapy. British Journal of Clinical Practice. Supplement. 1984; 36:5-11.
29. Gerrein JR, Rosenberg CM, Manohar V. Disulfiram maintenance in outpatient treatment of alcoholism. Archives of General Psychiatry. 1973; 28:798-802.
30. Robichaud C, Strickler D, Bigelow G, Liebson I. Disulfiram maintenance employee alcoholism treatment: A three-phase evaluation. Behaviour Research & Therapy. 1979; 17:618-21.
31. McCusker M. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction. 2001; 96:1007-14.
32. Azrin NH, Nunn RG, Frantz-Renshaw SE. Habit reversal vs. negative practice treatment of self-destructive oral habits (biting, chewing or licking of the lips, cheeks, tongue or palate). Journal of Behavior Therapy & Experimental Psychiatry. 1982; 13:49-54.
33. Wright C, Moore RD. Disulfiram treatment of alcoholism. American Journal of Medicine. 1990; 88:647-55.
34. Enghusen Poulsen H, Loft S, Andersen JR, Andersen M. Disulfiram therapy-adverse drug reactions and interactions. Acta Psychiatrica Scandinavica, Supplementum. 1992; 369:59-65; discussion 65-6.
35. Iber FL, Lee K, Lacoursiere R, Fuller R. Liver toxicity encountered in the Veterans Administration trial of disulfiram in alcoholics. Alcoholism: Clinical & Experimental Research. 1987; 11:301-4.
36. Goyer PF, Major LF. Hepatotoxicity in disulfiram-treated patients. Journal of Studies on Alcohol. 1979; 40:133-7.
37. Rothstein E. Safety of disulfiram (antabuse). New England Journal of Medicine. 1972; 286:162.
38. Wright CT, Vafier JA, Lake CR. Disulfiram-induced fulminating hepatitis: guidelines for liver-panel monitoring. Journal of Clinical Psychiatry. 1988; 49:430-4.
39. Wright C, Moore RD, Grodin DM, Spyker DA, Gill EV. Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program. Alcoholism: Clinical & Experimental Research. 1993; 17:184-6.
40. Rosman AS, Waraich A, Baraona E, Lieber CS. Disulfiram treatment increases plasma and red blood cell acetaldehyde in abstinent alcoholics. Alcoholism: Clinical & Experimental Research 2000: 24:958-64.
41. Saxon AJ, Sloan KL, Reoux J, Haver VM. Disulfiram use in patients with abnormal liver function test results. Journal of Clinical Psychiatry. 1998; 59:313-6.
42. Brewer C. Disulfiram for alcoholism. American Family Physician. 1993; 47:57.
43. Dilts SL, Dilts SL, Jr. Assessing liver function before initiating disulfiram therapy. American Journal of Psychiatry. 1996; 153:1504-5.
44. Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety. 1999; 20:427-35.